Wound Healing Phases

PHASES OF WOUND HEALING

Inflammatory phase (Start of injury up to 4 days)

Hemostasis

Vasoconstriction occurs soon after the tissue is damaged as injured vessels release serotonin, histamine, prostaglandins, and blood. Platelet aggregation and thromboplastin form a clot as fibrin binds the edges of the wound together and provides temporary wound closure.

Inflammation (1 to 4 days)

Lymphocytes trigger the inflammatory response, which increases capillary permeability (this causes wound edges to swell). Bacteria and other cellular debris (dead cells) are consumed by white blood cells. This reduces the formed clot. Macrophages mediate by releasing growth factors which increase the level of fibroblasts.

Proliferative phase (2-3 days to 30 days)

Fibroblasts lay the building blocks of the new extracellular matrix for collagen fibers and granulation tissue. Granulation tissue forms and that tissue fills in the open space of the wound. Angiogenesis, with capillary formation, connects blood flow into the newly developing granulating tissue. The wound begins to contract and epithelialization moves across and covers the surface of the wound.

Remodeling phase ( 3 weeks to 2 years)

Completion of contraction occurs as collagen fibers shorten and crosslink reducing the size of the scar, but increasing . This increases the tensile strength of the scar which will return to be approximately 80% as strong as the original tissue.

Wound Infection Symptoms

Signs and Symptoms for identifying wound infection

Pus (always an indication of infection)

Heat

Erythema

Swelling

Induration

Purulent or increased exudates

Wound bed discoloration (yellow/ green)

Increased odor

Non-healing wound

Wound deterioration

Unexpected extension of wound

Increased tenderness

Tissue bleeds easily

Fever of 101° F or greater

Elevated white cell count

Cellulitis

Inflammation

Nodules or pustules often precede ulceration

Local or regional lymphadenopathy may be present

Sudden appearance of necrosis

Unhealthy coloration/dullness of previously healing tissues

Wound Care Documentation for the ICU Patient

Intensive care patients with wounds require additional documentation to tell why they may be predisposed to skin failure.   

        Pre-albumin, albumin, transferrin levels

Use of vasoconstrictive agents

Mention if the patient is “too unstable to turn” or has to be “turned less often”

Days in bed and days without nutrition

Discuss low body mass index on admission

Discuss and document that you have discussed skin failure with the patient, family, and caregivers.

 

Skin Failure is “An event where skin and underlying tissues die due to  hypoperfusion that occurs concurrent with severe dysfunction or failure of other organ systems.”

Langemo D, Brown G Skin Fails Too, Acute, Chronic, and End-Stage Skin Failure. Advances in Skin Wound Care. 2006 May;19(4):206-212.

 

 

 

Apligraft Tips for Successful Placement

APLIGRAF

Apligraf consists of a living, active dermal layer composed of human fibroblasts derived from neonatal foreskin in a bovine type 1 collagen matrix and a living, active epidermal layer formed by human keratinocytes (with a well-differentiated stratum corneum). Apligraf contains matrix proteins, expresses cytokines, and produces an array of growth factors.

Organogenesis Inc., (2006). Apligraf – Structure and Composition. O1-3206

Preplacement of Apligraf:

Assess for a HbA1C of < 8 and for appropriate circulation

Aggressive debridement should be conducted prior to placement

including any callous

Apligraf should not be applied to infected wounds

Stop all silver products because of cellular death to Apligraf cells

Consider a wound VAC for higher exudating wounds (place a non adherent 

layer –Mepitel, keep VAC between 50-75mmHg, place for only 5-14 days)

No cytotoxic agents

Placement of Apligraf

Irrigate with wound bed with sterile saline

Place the dermal (glossier) layer directly in contact with the wound bed

or fenestrate the Apligraf especially if drainage is present

Remove air pockets with a sterile cotton-tip applicator.

Secure Apligraf with staples, sutures ,steri strips, or glue.

Place Mepitel as the primary dressing

Place a foam dressing for absorption and protection

For Diabetic Foot Ulcers

Outcomes improve when the patients HbA1C is less than 8.

Cover Apligraf with a nonadherent primary dressing (Mepitel)

Apply and secure a foam pressure bolster or absorbent secondary

dressing,  secure dressings with a rolled gauze or web roll.

Offload

For Venous Insufficiency Ulcers

After placement of Apligraf use appropriate compression

Assessment of placed Apligraf

Secondary dressings should be changed 5 to 7 days after application

depending on drainage.

The primary dressing should be left in place for 14 days

Translucent, cellophane-like appearance within 1 week

Yellow, gelatinous appearance when fully hydrated

Apligraf may take on the appearance of a yellow or whitish

gelatinous material (which is often mistaken as slough)

(Organogenesis, Inc., 2007)

Note: It may take 2 to 4 weeks to see a significant improvement

in the wound. Don’t debride for 4 weeks as Apligraf cells may persist

for 4 weeks

Organogenesis, Inc., 2007, A Reference Guide for Apligraf. 01/07 APG-8146

Controlling a bleeding wound

What do you do if the wound starts bleeding out?  

Typically, compression (physical pressure with 4×4 guaze) is enough to stop wound bleeding. If bleeding persists consider Surgicel hemostatic dressing. Past this point silver nitrate is a good option to stop bleeding at specific locations in the wound bed (Check your facility protocol because this may be restricted to a physican’s scope of practice). If there is a copious bleeding wound contact the physican or surgeon immediately. If you fear for the patients safety don’t be afraid to call a code in order to get physican help STAT. Expect an order for an H& H and to Type and Cross for PRBCs. The surgeon may need to cauterize or tie of the open vessel or vessels (have a suture kit available).

Other ideas:

Obviously hold the NPWT until stable

Check to see if the patient has a coagulation disorder or is taking an

   anticoagulant or antiplatelet medication.

Direct pressure 10 – 15 minutes

Ice packs

Calcium alginate or Hydrofiber dressings

Gauze soaked in 1:1000 epinephrine over the bleeding area

Topical absorbable hemostatic sponge or foam – Gelfoam

Hemostatic dressings or substances

Surgicel, Oxycel, Thrombin, Gelfoam, Rapid Deployment Hemostat, Avitene, Hemarrest, Hemostatin, Sorbstace , Microcaps, TraumaDex

Silver nitrate sticks

Topical low dose (100u/ml) thromboplastin

Cautery (hand held or electric)

Follow

Get every new post delivered to your Inbox.